EMA shake-up focuses on agency role as data and knowledge provider
This article was originally published in SRA
Executive Summary
The European Medicines Agency is to be restructured to fulfil three key objectives of better supporting the agency’s scientific committees, sharing more data, and meeting the needs of stakeholders1.